Literature DB >> 6272516

Presence of gangliosides in the structure of membrane receptor for thyrotrophin.

A Gardas, J Nauman.   

Abstract

Thyroid gangliosides were isolated from bovine thyroid tissue. Neutral lipids and glycolipids were removed by chromatography on a DEAE-cellulose column and residual acidic phospholipids by alkaline degradation. Thyroid gangliosides were separated by chromatography on a silica acid column into 9 different fractions. Thyroid gangliosides were found to be active in the inhibition of [125I]TSH binding to thyroid plasma membranes and this results from a direct action between thyrotrophin and gangliosides. The most active fraction contained gangliosides with two sialic acids per molecule. Pre-incubation of thyroid plasma membranes for 4 hours at 37 degrees C with gangliosides and removal of the unbound gangliosides increased the [125I]TSH binding to pre-treated membranes by 10-20%. Anti-ganglioside antibodies obtained by immunisation of rabbits inhibited [125I]TSH binding to thyroid plasma membranes by 60 to 80%. The thyroxine (T4) level in blood serum of immunized animals was significantly decreased after the first immunization and T4 become almost undetectable after the booster injection implying that antibodies against thyroid gangliosides produce severe impairment of thyroid cell function.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6272516     DOI: 10.1530/acta.0.0980549

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  3 in total

Review 1.  Specificities of autoantibodies in autoimmune receptor diseases.

Authors:  M H De Baets
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

2.  Direct evidence that ganglioside is an integral component of the thyrotropin receptor.

Authors:  W Kielczynski; L C Harrison; P J Leedman
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

3.  Effects of thyrotropin and thyroid stimulating immunoglobulins on gangliosides labelling of human thyroid cultured pathological cells.

Authors:  J Etienne-Decerf; C Gosselin-Rey; L Gosselin; R Winand
Journal:  J Endocrinol Invest       Date:  1986-02       Impact factor: 4.256

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.